Windtree Therapeutics Overview
- Year Founded
-
1992
- Status
-
Out of Business
- Employees
-
29
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
28
- Investments
-
6
Windtree Therapeutics General Information
Description
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
Contact Information
Website
www.windtreetx.comCorporate Office
- 2600 Kelly Road
- Suite 100
- Warrington, PA 18976-3622
- United States
Corporate Office
- 2600 Kelly Road
- Suite 100
- Warrington, PA 18976-3622
- United States
Windtree Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Windtree Therapeutics Comparisons
Industry
Financing
Details
Windtree Therapeutics Competitors (18)
One of Windtree Therapeutics’s 18 competitors is Tenaya Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tenaya Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Avalyn Pharma | Formerly VC-backed | Boston, MA | ||||
| Savara | Formerly VC-backed | Yardley, PA | ||||
| Aqualung Therapeutics | Venture Capital-Backed | Tucson, AZ | ||||
| Verve Therapeutics | Formerly VC-backed | Boston, MA |
Windtree Therapeutics Patents
Windtree Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024399423-A1 | Istaroxime and metabolite derivatives thereof for reducing the risk of acute myocardial arrhythmia | Pending | 11-Dec-2023 | ||
| EP-4823583-A1 | Istaroxime and metabolite derivatives thereof for reducing the risk of acute myocardial arrhythmia | Pending | 11-Dec-2023 | ||
| WO-2025128432-A1 | Istaroxime and metabolite derivatives thereof for reducing the risk of acute myocardial arrhythmia | Inactive | 11-Dec-2023 | ||
| EP-4634177-A1 | Solid forms of {5-cyclopropyl-2-[2-(3,6-difluoro- pyridin-2-ylamino)-pyridin-4-yl]-pyrido[3,4-d]pyrimidin-4-yl}-((s)-3,3-dimethyl-piperidin-4-yl)-amine | Pending | 13-Dec-2022 | ||
| JP-2026500270-A | Solid forms of {5-cyclopropyl-2-[2-(3,6-difluoro-pyridin-2-ylamino)-pyridin-4-yl]-pyrido[3,4-d]pyrimidin-4-yl}-((s)-3,3-dimethyl-piperidin-4-yl)-amine | Pending | 13-Dec-2022 | C07D471/04 |
Windtree Therapeutics Signals
Windtree Therapeutics Investments & Acquisitions (6)
Windtree Therapeutics’s most recent deal was a Corporate Asset Purchase with Windtree Therapeutics (436 Unit Multifamily Residential Property in Houston, Texas) for . The deal was made on 01-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Windtree Therapeutics (436 Unit Multifamily Residential Property in Houston, Texas) | 01-May-2025 | Corporate Asset Purchase | Buildings and Property | ||
| Varian Biopharmaceuticals | 02-Apr-2024 | Merger/Acquisition | Drug Discovery | ||
| KatKin | 08-Aug-2022 | Early Stage VC | Other Consumer Non-Durables | ||
| CVie Therapeutics Company | 21-Dec-2018 | Merger/Acquisition | Drug Discovery | ||
| AEROSURF | 15-Oct-2014 | Joint Venture | Managed Care |
Windtree Therapeutics FAQs
-
When was Windtree Therapeutics founded?
Windtree Therapeutics was founded in 1992.
-
Where is Windtree Therapeutics headquartered?
Windtree Therapeutics is headquartered in Warrington, PA.
-
What is the size of Windtree Therapeutics?
Windtree Therapeutics has 29 total employees.
-
What industry is Windtree Therapeutics in?
Windtree Therapeutics’s primary industry is Biotechnology.
-
Is Windtree Therapeutics a private or public company?
Windtree Therapeutics is a Private company.
-
What is Windtree Therapeutics’s current revenue?
The current revenue for Windtree Therapeutics is .
-
How much funding has Windtree Therapeutics raised over time?
Windtree Therapeutics has raised $633M.
-
Who are Windtree Therapeutics’s competitors?
Tenaya Therapeutics, Avalyn Pharma, Savara, Aqualung Therapeutics, and Verve Therapeutics are some of the 18 competitors of Windtree Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process